Written & medically reviewed by Dr. Albana Greca, MD, MMedSc • Family Physician / General Practitioner • Last medically reviewed: August 2026
Original Question:

“What is the difference between the Gleason score found on a prostate biopsy and the Gleason score found after surgery? What numbers should we look at to better understand the current situation of a person with prostate cancer?”

Quick Answer

The Gleason score or Grade Group from a prostate biopsy is an estimate based on small samples of the prostate. After radical prostatectomy, the pathologist can examine the entire prostate, so the surgical pathology usually gives a more complete picture of the cancer’s grade and extent.

This means the final Grade Group may be higher, lower or the same as the biopsy Grade Group.

To understand the situation after surgery, do not look at Gleason score alone. Important findings include the final Grade Group, pathological stage, surgical margins, whether cancer has extended outside the prostate, seminal-vesicle involvement, lymph-node findings and the PSA after surgery.

What Is the Gleason Score?

The Gleason system describes how prostate cancer looks under the microscope.

A pathologist identifies the main patterns of cancer growth and assigns each a pattern number. In current prostate-cancer practice, the important patterns are usually Gleason patterns 3, 4 and 5.

Two patterns are then combined to produce the Gleason score.

For example:

  • 3 + 3 = 6
  • 3 + 4 = 7
  • 4 + 3 = 7
  • 4 + 4 = 8
  • 4 + 5 = 9

The first number generally represents the predominant pattern, while the second represents another important pattern identified by the pathologist.

What Are Grade Groups?

Today, doctors commonly report both the traditional Gleason score and the simpler ISUP Grade Group.

Grade Group Gleason score General interpretation
Grade Group 1 3 + 3 = 6 Lowest grade routinely assigned to prostate cancer diagnosed using the modern Gleason system.
Grade Group 2 3 + 4 = 7 Mostly pattern 3 cancer with some higher-grade pattern 4.
Grade Group 3 4 + 3 = 7 More pattern 4 than pattern 3; generally more concerning than 3 + 4.
Grade Group 4 Gleason 8 High-grade prostate cancer.
Grade Group 5 Gleason 9–10 Highest Grade Group and associated with more aggressive biological behavior.
Important:
A Gleason score of 7 is not one single category. Gleason 3+4 and 4+3 have different Grade Groups because a cancer dominated by pattern 4 generally carries a less favorable prognosis than one dominated by pattern 3.

Why Can the Biopsy and Surgery Scores Be Different?

The main reason is sampling.

A prostate biopsy removes multiple small tissue cores, but these samples still represent only portions of the prostate.

Prostate cancer can also be heterogeneous, meaning one part of the tumor may contain a different grade than another part.

For example, a biopsy might sample mostly Gleason pattern 3 even though another area of the prostate contains more pattern 4.

After radical prostatectomy, the entire prostate is available for detailed pathological examination.

That gives the pathologist much more tissue and may reveal areas that were not captured by the biopsy.

What Does “Upgrading” Mean?

Upgrading means that the prostatectomy specimen shows a higher Grade Group than the original biopsy.

For example:

Biopsy: Gleason 3+3=6, Grade Group 1
Surgery: Gleason 3+4=7, Grade Group 2

This does not usually mean that the cancer suddenly became more aggressive between the biopsy and surgery.

More often, it means that the biopsy did not sample the higher-grade area that was subsequently found when the whole prostate was examined.

What Does “Downgrading” Mean?

The opposite can also occur.

Downgrading means the final prostatectomy Grade Group is lower than the biopsy suggested.

For example:

Biopsy: Gleason 4+3=7, Grade Group 3
Surgery: Gleason 3+4=7, Grade Group 2

Again, this does not necessarily mean that surgery changed the cancer grade. It reflects the greater amount of tissue available for final pathological assessment.

Which Result Is More Complete?

If the entire prostate has been removed by radical prostatectomy, the prostatectomy pathology generally provides a more complete assessment of the removed cancer than the preoperative biopsy.

However, the biopsy remains extremely important because it helps doctors estimate risk and select treatment before surgery.

The biopsy is interpreted together with:

  • PSA
  • PSA density
  • MRI findings
  • number and location of positive biopsy cores
  • amount of cancer in each core
  • Grade Group
  • clinical stage
  • other risk factors

What Should You Check on the Prostatectomy Pathology Report?

If a person has undergone radical prostatectomy, I would look beyond the Gleason number.

The final report contains several findings that help estimate recurrence risk and determine whether additional treatment or closer follow-up may be needed.

1. Final Gleason Score and Grade Group

This describes the microscopic aggressiveness of the cancer found in the removed prostate.

2. Pathological T Stage

This describes how far the cancer extended locally.

Pathological finding What it generally means
pT2 Cancer is confined within the prostate.
pT3a Cancer has extended outside the prostate.
pT3b Cancer has invaded the seminal vesicle or vesicles.
pT4 Tumor has invaded certain nearby structures other than the seminal vesicles.

3. Surgical Margins

The pathologist checks the edges of the removed tissue.

A negative margin means cancer cells were not identified at the inked surgical edge.

A positive margin means cancer cells are present at the surgical margin.

A positive margin may increase the risk of biochemical recurrence, but it does not automatically mean visible cancer remains or that recurrence is inevitable.

4. Extraprostatic Extension

This means cancer has grown beyond the normal boundary of the prostate.

The pathology report may describe whether this extension is focal or more extensive.

5. Seminal Vesicle Invasion

Involvement of the seminal vesicles is an important adverse pathological finding and is classified as pT3b disease.

6. Lymph Nodes

If lymph nodes were removed during surgery, the pathology report should state how many were examined and whether any contained prostate cancer.

A report might therefore show something such as:

0/12 lymph nodes involved

meaning 12 nodes were examined and none contained cancer.

7. Cribriform or Intraductal Cancer

Modern pathology reports may also mention cribriform architecture or intraductal carcinoma.

These features can provide additional prognostic information and are particularly relevant when interpreting cancers containing Gleason pattern 4.

Which Numbers Matter Most?

There is no single number that describes the entire prostate-cancer situation.

Before treatment, doctors typically combine several factors.

Finding Why it matters
PSA Provides information about prostate-cancer risk and is used with grade and stage.
Grade Group Describes how aggressive the cancer appears microscopically.
Clinical stage Estimates the extent of disease before definitive treatment.
MRI/imaging Helps identify suspicious lesions and possible disease beyond the prostate.
Biopsy extent Includes how many cores contain cancer and how much cancer is present.

After radical prostatectomy, the final pathology adds more precise information about the actual cancer removed.

Does a Low Gleason Score Mean the Cancer Is Definitely Confined?

No.

A lower Grade Group generally indicates less aggressive-looking cancer, but grade and stage describe different things.

Grade describes what the cancer looks like microscopically.

Stage describes how far the cancer has spread anatomically.

A lower-grade cancer is more likely to have favorable characteristics, but Gleason score alone cannot prove that the disease is confined to the prostate.

This is why doctors consider the Grade Group together with PSA, examination, MRI and other staging information.

Does a Higher Gleason Score Mean Surgery Cannot Work?

No.

A higher Grade Group is associated with a greater risk of recurrence or disease outside the prostate, but it does not by itself determine whether surgery can be successful.

Treatment decisions depend on the complete clinical picture, including:

  • Grade Group
  • PSA
  • clinical stage
  • MRI and other imaging
  • lymph-node or metastatic findings
  • age and general health
  • expected life expectancy
  • patient preferences

Some men with high-risk disease undergo radical prostatectomy as part of a treatment strategy, while others may be better suited to radiation combined with hormone therapy or another approach.

Does Removing the Prostate Mean the Cancer Can Never Return?

No.

The old version of this article implied that completely removing the prostate means prostate cancer cannot develop again.

Unfortunately, recurrence is still possible.

Microscopic cancer cells may sometimes already exist outside the removed prostate even when they were too small to identify before surgery.

This is why men continue to have PSA monitoring after radical prostatectomy.

A good surgical result does not mean follow-up ends.
The prostatectomy pathology gives important information about recurrence risk, but PSA monitoring remains necessary after surgery.

What Happens to PSA After Radical Prostatectomy?

Because most PSA-producing prostate tissue has been removed, PSA is expected to fall to an undetectable or extremely low level after radical prostatectomy.

Current European guidance states that PSA is expected to be undetectable by approximately two months after surgery.

A PSA that remains measurable or begins rising later requires interpretation by the treating urologist or oncology team.

You can read more about PSA interpretation in my PSA guide.

Is the Gleason Score Checked Again During Follow-Up?

Not through a blood test.

The Gleason score is a microscopic pathology measurement.

After the prostate has been removed, the final Grade Group comes from examination of the prostatectomy specimen.

Routine follow-up then focuses primarily on:

  • PSA
  • symptoms
  • treatment side effects
  • additional imaging when clinically indicated

The Gleason score itself does not rise and fall during follow-up in the way PSA can.

An Example of How to Read the Results

Example:

Biopsy: Gleason 3+4=7, Grade Group 2
Preoperative PSA: 8.2 ng/mL
Surgery: Gleason 4+3=7, Grade Group 3
Stage: pT3a
Margins: Negative
Seminal vesicles: Negative
Lymph nodes: 0/10 positive
Postoperative PSA: Undetectable

In this example, the cancer was upgraded from Grade Group 2 to Grade Group 3 after the whole prostate was examined.

The pT3a result indicates extension outside the prostate, while negative margins and negative lymph nodes are favorable findings.

An undetectable postoperative PSA is also reassuring, but continued PSA follow-up is still necessary.

The treating team would interpret all of these findings together rather than making a prediction from the Gleason score alone.

Why Modern MRI Has Improved Biopsy Accuracy

MRI-targeted biopsy has improved our ability to sample suspicious prostate lesions and detect clinically significant cancer.

However, it does not eliminate sampling error completely.

This is why a man’s final prostatectomy pathology can still differ from his MRI-targeted biopsy.

Dr. Albana’s perspective:
When families compare the biopsy report with the surgical pathology report, I tell them not to become alarmed simply because the Gleason score changed. The biopsy examined samples; the surgery allows examination of the entire removed prostate. The final situation is best understood by looking at the Grade Group together with pathological stage, margins, seminal-vesicle findings, lymph nodes and the postoperative PSA. No single number tells the whole story.